| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 268 | 20.271 | 1.670 | 0 | 84.292 | 231.146 | 260.952 | 37.025 | 17.551 | 2.239 |
| Total Income - EUR | 268 | 20.271 | 1.670 | 0 | 84.292 | 231.146 | 261.040 | 37.072 | 17.574 | 2.277 |
| Total Expenses - EUR | 63 | 261 | 551 | 126 | 598 | 162.037 | 182.662 | 7.460 | 8.067 | 10.206 |
| Gross Profit/Loss - EUR | 206 | 20.010 | 1.120 | -126 | 83.694 | 69.109 | 78.378 | 29.612 | 9.507 | -7.929 |
| Net Profit/Loss - EUR | 198 | 19.402 | 1.070 | -126 | 82.851 | 66.847 | 75.821 | 29.286 | 9.352 | -7.929 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Biotriticum Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 98 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 318 | 19.871 | 20.380 | 19.880 | 119.649 | 203.320 | 78.017 | 30.746 | 28.447 | 1.861 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 39.288 | 2.239 | 2.246 | 2.239 | 0 |
| Receivables | 0 | 42 | 0 | 0 | 63.008 | 88.573 | 35.058 | 2.989 | 17.931 | 1.531 |
| Cash | 318 | 19.829 | 20.380 | 19.880 | 56.641 | 75.459 | 40.720 | 25.511 | 8.277 | 330 |
| Shareholders Funds | 243 | 19.643 | 20.380 | 19.880 | 102.346 | 101.968 | 75.869 | 29.335 | 27.611 | -62 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 173 | 228 | 0 | 0 | 17.303 | 101.352 | 2.148 | 1.411 | 836 | 1.923 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Biotriticum Srl